Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,216.00
Bid: 12,216.00
Ask: 12,220.00
Change: 46.00 (0.38%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Pound lifted to one-month high by gilt yield rise, Omicron reassurance

Thu, 23rd Dec 2021 11:24

(Updates throughout, adds quote)

By Sujata Rao

LONDON, Dec 23 (Reuters) - Sterling vaulted above $1.34 for
the first time in a month on Thursday and also scaled a
one-month high against the euro, surfing a general uptick in
risk sentiment and a steep rise in Britain's short-dated
government bond yields.

UK businesses posted the weakest quarterly growth since the
three months to April when lockdowns were in effect, the
Confederation of British Industry (CBI) said.

But that was offset by an announcement from AstraZeneca
that a three-dose course of COVID-19 vaccine was
effective against Omicron. Rivals Pfizer-BioNTech and Moderna,
also say a third shot of their vaccines works against Omicron.

Coming after reports that Omicron patients are less likely
to need hospitalisation, the news raised hopes that governments
may not need to widen restrictions on activities.

Britain also cut its COVID-19 self-isolation period to seven
days from 10 days for those who test negative two days in a row.
.

By 1530 GMT, the pound was up 0.5% against the dollar at
$1.34190, just off a one-month peak of $1.34370 hit earlier
. Against the euro, it was up 0.55% at 84.360 pence
having risen as high as 84.16 pence.

Analysts pointed to steep rises in UK gilt yields,
outstripping German and U.S. peers, with 5- and 10-year yields
up five basis points (bps) on the day as markets moved to factor
a 100 bps rise in British interest rates by end-2022
.

Nomura strategist Jordan Rochester noted especially the
pick-up in UK "real" or inflation-adjusted yields. British
5-year real yields jumped 14 bps on the day, bringing gains
since mid-December to around 60 bps. U.S. and German
counterparts have flatlined in this period, Refinitiv data shows

"If you're looking for why sterling remains bid, it's the
continued pickup in real yields," Rochester said, though he
suggested the moves were down to Christmas volumes "rather than
the start of a new uptrend" with the positive impulse from UK
rate hikes already largely priced in.

The pound has risen 1.6% and 1.2% against the dollar and
euro respectively since Dec. 15, a day before the Bank of
England hiked interest rates.

Scotiabank analysts pointed out 2-year gilt yields were up
30 bps in the past 10 days, while the Bund equivalent had risen
less than five bps. That's seen the spread between the two
approach the widest since August 2019 <GB2DE2.

"As we had expected, the move in yields is pulling
euro/sterling toward the 84 pence level," they said.

(Reporting by Sujata Rao Editing by Bernadette Baum and Mark
Potter)

More News
Today 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
Today 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.